Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Rigid Bronchoscopy Anesthesia
NCT05468671Phase 4Completed
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Jan 2021
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of remimazolam in metastatic disease (METS) and Bronchoesophageal fistula (BOF) (2 arms), sponsored by Zhejiang Cancer Hospital. Primary endpoint: Recovery time. Started Jan 2021; status: completed.
02
Drugs
remimazolam
03
Conditions
metastatic disease (METS)Bronchoesophageal fistula (BOF)
Beyond the preview
Go deeper on NCT05468671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05468671.